{"transactions":[{"id":4053,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-04T01:39:55.000Z","date":"2026-09-02","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a gift/charitable contribution effective September 2, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares."}],"balance_after":14860,"source":{"system":"sec-edgar","filing":"0001079462-26-000008","document":"wk-form4_1788485992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000107946226000008/wk-form4_1788485992.xml","form_type":"4"}},{"id":742300,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-11T21:47:54.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026."}],"balance_after":15193,"source":{"system":"sec-edgar","filing":"0000875045-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000064/form4.xml","form_type":"4"}},{"id":745359,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option was granted May 22, 2019 and vested in 12 equal monthly installments beginning June 22, 2019."}],"balance_after":0,"derivative":{"exercise_price":79.79,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745358,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was granted May 22, 2017 and vested in 12 equal monthly installments beginning June 22, 2017."}],"balance_after":0,"derivative":{"exercise_price":53.64,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745357,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":1843,"price":167.3128,"value":308357.4904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $167.11 to $167.70.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15860,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745356,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":5829,"price":166.5567,"value":970859.0043,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $166.11 to $167.09.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17703,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745355,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":6896,"price":165.7926,"value":1143305.7696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $165.11 to $166.09.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":23532,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745354,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":2549,"price":164.4394,"value":419156.0306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $164.11 to $164.83.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":30428,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745353,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":7883,"price":163.807,"value":1291290.581,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $163.11 to $164.10.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":32977,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745352,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":79.79,"value":797900.0,"ownership":{"direct":true},"balance_after":40860,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":745351,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:34.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":53.64,"value":804600.0,"ownership":{"direct":true},"balance_after":30860,"source":{"system":"sec-edgar","filing":"0001079462-26-000006","document":"wk-form4_1781041231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000006/wk-form4_1781041231.xml","form_type":"4"}},{"id":759320,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restriced Stock Unit","published_at":"2026-05-29T22:03:06.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."}],"balance_after":2567,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2567},"source":{"system":"sec-edgar","filing":"0001079462-26-000004","document":"wk-form4_1780092183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000004/wk-form4_1780092183.xml","form_type":"4"}},{"id":768861,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T23:24:56.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0001079462-26-000002","document":"wk-form4_1779405893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000002/wk-form4_1779405893.xml","form_type":"4"}},{"id":768860,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T23:24:56.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15860,"source":{"system":"sec-edgar","filing":"0001079462-26-000002","document":"wk-form4_1779405893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000107946226000002/wk-form4_1779405893.xml","form_type":"4"}},{"id":1050567,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T22:47:36.000Z","date":"2025-09-02","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a gift/charitable contribution effective September 2, 2025. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares."}],"balance_after":12542,"source":{"system":"sec-edgar","filing":"0000914475-25-000169","document":"wk-form4_1756939653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000169/wk-form4_1756939653.xml","form_type":"4"}},{"id":1106950,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-18T20:42:37.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13688,"source":{"system":"sec-edgar","filing":"0001127602-25-017759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225017759/form4.xml","form_type":"4"}},{"id":1138143,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:26:17.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2869},"source":{"system":"sec-edgar","filing":"0000914475-25-000130","document":"wk-form4_1747949168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000130/wk-form4_1747949168.xml","form_type":"4"}},{"id":1138142,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:26:17.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."}],"balance_after":3318,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0000914475-25-000130","document":"wk-form4_1747949168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000130/wk-form4_1747949168.xml","form_type":"4"}},{"id":1138141,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:26:17.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13542,"source":{"system":"sec-edgar","filing":"0000914475-25-000130","document":"wk-form4_1747949168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000130/wk-form4_1747949168.xml","form_type":"4"}},{"id":1216291,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-10T20:09:42.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":8760,"price":150.0162,"value":1314141.912,"ownership":{"direct":true},"balance_after":11318,"source":{"system":"sec-edgar","filing":"0001127602-25-008861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225008861/form4.xml","form_type":"4"}},{"id":1268339,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-14T23:49:28.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":13831,"price":116.6888,"value":1613922.7928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.79 to $118.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":10673,"source":{"system":"sec-edgar","filing":"0000914475-25-000071","document":"wk-form4_1739576962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000071/wk-form4_1739576962.xml","form_type":"4"}},{"id":1373361,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T00:42:38.000Z","date":"2024-11-04","kind":"gift","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a gift/charitable contribution effective November 4, 2024. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares."}],"balance_after":24504,"source":{"system":"sec-edgar","filing":"0000914475-24-000218","document":"wk-form4_1731026551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000218/wk-form4_1731026551.xml","form_type":"4"}},{"id":1469989,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-25T21:20:49.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":1340,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20078,"source":{"system":"sec-edgar","filing":"0001127602-24-019240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224019240/form4.xml","form_type":"4"}},{"id":1498409,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016. These options will expire ten years from the date of grant on May 20, 2026."}],"balance_after":0,"derivative":{"exercise_price":47.89,"expiration_date":"2026-05-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1498408,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025."}],"balance_after":0,"derivative":{"exercise_price":42.76,"expiration_date":"2025-05-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1498407,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":133.4673,"value":2002009.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.00 to $136.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26504,"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1498406,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":47.89,"value":718350.0,"ownership":{"direct":true},"balance_after":41504,"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1498405,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":133.4622,"value":3336555.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.22 to $136.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":26504,"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1498404,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:38:30.000Z","date":"2024-05-29","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":42.76,"value":1069000.0,"ownership":{"direct":true},"balance_after":51504,"source":{"system":"sec-edgar","filing":"0000914475-24-000160","document":"wk-form4_1717101501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000160/wk-form4_1717101501.xml","form_type":"4"}},{"id":1504412,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T22:29:36.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."}],"balance_after":2869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2869},"source":{"system":"sec-edgar","filing":"0000914475-24-000152","document":"wk-form4_1716503359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000152/wk-form4_1716503359.xml","form_type":"4"}},{"id":1507781,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-21T20:51:02.000Z","date":"2024-05-17","kind":"exercise","planned":false,"acquired":false,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4199},"source":{"system":"sec-edgar","filing":"0000914475-24-000127","document":"wk-form4_1716324649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000127/wk-form4_1716324649.xml","form_type":"4"}},{"id":1507780,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:51:02.000Z","date":"2024-05-17","kind":"exercise","planned":false,"acquired":true,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26504,"source":{"system":"sec-edgar","filing":"0000914475-24-000127","document":"wk-form4_1716324649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000127/wk-form4_1716324649.xml","form_type":"4"}},{"id":1735299,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-20T21:10:21.000Z","date":"2023-11-16","kind":"gift","planned":false,"acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a gift/charitable contribution effective November 16, 2023. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares."}],"balance_after":22305,"source":{"system":"sec-edgar","filing":"0001209191-23-056033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123056033/doc4.xml","form_type":"4"}},{"id":1843020,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-28T23:10:18.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":960,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18738,"source":{"system":"sec-edgar","filing":"0001127602-23-019548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223019548/form4.xml","form_type":"4"}},{"id":1885697,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-19T21:24:36.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units will vest in full on May 17, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units will vest in full on May 17, 2024."}],"balance_after":4199,"derivative":{"underlying":"Common Stock","underlying_shares":4199},"source":{"system":"sec-edgar","filing":"0001209191-23-031131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123031131/doc4.xml","form_type":"4"}},{"id":2044278,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-27T23:28:38.000Z","date":"2022-11-15","kind":"gift","acquired":false,"shares":695,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17778,"source":{"system":"sec-edgar","filing":"0001127602-23-002502","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002502/form5.xml","form_type":"5"}},{"id":2064051,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted May 22, 2014 and vested monthly over one year."}],"balance_after":0,"derivative":{"exercise_price":12.98,"expiration_date":"2024-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2064050,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15000,"price":12.71,"value":190650.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted May 23, 2013 and vested monthly over one year."}],"balance_after":0,"derivative":{"exercise_price":12.71,"expiration_date":"2023-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2064049,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":15000,"price":118.8501,"value":1782751.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $117.75 to $119.74. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":25055,"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2064048,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"balance_after":40055,"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2064047,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":15000,"price":118.8651,"value":1782976.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $117.75 to $119.74. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":25055,"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2064046,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:21:11.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15000,"price":12.71,"value":190650.0,"ownership":{"direct":true},"balance_after":40055,"source":{"system":"sec-edgar","filing":"0001209191-23-002054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002054/doc4.xml","form_type":"4"}},{"id":2228925,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-17T21:16:13.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":1370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18473,"source":{"system":"sec-edgar","filing":"0001127602-22-017811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222017811/form4.xml","form_type":"4"}},{"id":2262530,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-05-20T20:18:28.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":9724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 monthly installments beginning June 18, 2022."}],"balance_after":9724,"derivative":{"exercise_price":84.95,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":9724},"source":{"system":"sec-edgar","filing":"0001209191-22-031003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122031003/doc4.xml","form_type":"4"}},{"id":2425588,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-01-26T22:52:37.000Z","date":"2022-01-24","kind":"exercise","acquired":false,"shares":15000,"price":6.66,"value":99900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted May 23, 2012 and vested monthly over one year."}],"balance_after":0,"derivative":{"exercise_price":6.66,"expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-005109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122005109/doc4.xml","form_type":"4"}},{"id":2425587,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-26T22:52:37.000Z","date":"2022-01-24","kind":"sale","acquired":false,"shares":15000,"price":74.4252,"value":1116378.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $73.21 to $75.36. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":25055,"source":{"system":"sec-edgar","filing":"0001209191-22-005109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122005109/doc4.xml","form_type":"4"}},{"id":2425586,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-26T22:52:37.000Z","date":"2022-01-24","kind":"exercise","acquired":true,"shares":15000,"price":6.66,"value":99900.0,"ownership":{"direct":true},"balance_after":40055,"source":{"system":"sec-edgar","filing":"0001209191-22-005109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122005109/doc4.xml","form_type":"4"}},{"id":2470584,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T23:44:31.000Z","date":"2021-12-14","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents gift/charitable donations effective December 14, 2021. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares."}],"balance_after":25055,"source":{"system":"sec-edgar","filing":"0001209191-21-070071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121070071/doc4.xml","form_type":"4"}},{"id":2646241,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-02T21:33:18.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17103,"source":{"system":"sec-edgar","filing":"0001127602-21-021349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221021349/form4.xml","form_type":"4"}},{"id":2703967,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2021-05-20T20:10:57.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":8833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 19, 2021."}],"balance_after":8833,"derivative":{"exercise_price":92.35,"exercise_date":"2021-06-19","expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":8833},"source":{"system":"sec-edgar","filing":"0001209191-21-034389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121034389/doc4.xml","form_type":"4"}},{"id":2955634,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T00:23:33.000Z","date":"2020-12-03","kind":"gift","acquired":false,"shares":2806,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27055,"source":{"system":"sec-edgar","filing":"0001209191-20-062016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919120062016/doc4.xml","form_type":"4"}},{"id":3121181,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-05T21:24:36.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16328,"source":{"system":"sec-edgar","filing":"0001127602-20-019033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220019033/form4.xml","form_type":"4"}},{"id":3132608,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-28T23:56:50.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of May 5, 2020, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-20-011286","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000156761920011286/doc1.xml","form_type":"4"}},{"id":3139711,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2020-05-21T23:00:50.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":6018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 19, 2020."}],"balance_after":6018,"derivative":{"exercise_price":119.93,"exercise_date":"2020-06-19","expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":6018},"source":{"system":"sec-edgar","filing":"0001209191-20-031502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919120031502/doc4.xml","form_type":"4"}},{"id":3159953,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T01:08:37.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option which was outstanding immediately prior to the Effective Time (whether or not then vested or exercisable) was cancelled and converted automatically into the right to receive, as soon as reasonably practicable after the Effective Time (but no later than ten business days thereafter), a cash payment in an amount equal to the product of (i) the total number of Shares subject to such option immediately prior to such cancellation and (ii) the excess, if any, of the Cash Merger Consideration over the exercise price per Share subject to such option immediately prior to such cancellation."}],"balance_after":0,"derivative":{"exercise_price":2.65,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001694187-20-000070","document":"wf-form4_158881369954858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000169418720000070/wf-form4_158881369954858.xml","form_type":"4"}},{"id":3159952,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T01:08:37.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":18500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":4.64,"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001694187-20-000070","document":"wf-form4_158881369954858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000169418720000070/wf-form4_158881369954858.xml","form_type":"4"}},{"id":3159951,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-07T01:08:37.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":16,"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001694187-20-000070","document":"wf-form4_158881369954858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000169418720000070/wf-form4_158881369954858.xml","form_type":"4"}},{"id":3159950,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T01:08:37.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001694187-20-000070","document":"wf-form4_158881369954858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000169418720000070/wf-form4_158881369954858.xml","form_type":"4"}},{"id":3166829,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-30T20:27:05.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":17687,"price":99.3931,"value":1757965.7597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $97.34 to $102.34. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29861,"source":{"system":"sec-edgar","filing":"0001209191-20-026306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919120026306/doc4.xml","form_type":"4"}},{"id":3214424,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"exercise","acquired":false,"shares":1355,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.82,"exercise_date":"2011-03-22","expiration_date":"2020-03-22","underlying":"Common Stock","underlying_shares":1355},"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3214423,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"exercise","acquired":false,"shares":10923,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.82,"expiration_date":"2020-03-22","underlying":"Common Stock","underlying_shares":10923},"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3214422,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":270,"price":295.29,"value":79728.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":15438,"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3214421,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"exercise","acquired":true,"shares":1355,"price":58.46,"value":79213.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was previously reported as covering 1,325 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":15708,"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3214420,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":2164,"price":295.215,"value":638845.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":14353,"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3214419,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-12T22:56:29.000Z","date":"2020-03-11","kind":"exercise","acquired":true,"shares":10923,"price":58.46,"value":638558.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 10,675 shares at an exercise price of $59.82 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":16517,"source":{"system":"sec-edgar","filing":"0001127602-20-010505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220010505/form4.xml","form_type":"4"}},{"id":3283278,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-10T23:33:57.000Z","date":"2019-11-04","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001127602-20-004705","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220004705/form5.xml","form_type":"5"}},{"id":3283277,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-10T23:33:57.000Z","date":"2019-11-04","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001127602-20-004705","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220004705/form5.xml","form_type":"5"}},{"id":3283276,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-10T23:33:57.000Z","date":"2019-11-04","kind":"gift","acquired":false,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001127602-20-004705","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220004705/form5.xml","form_type":"5"}},{"id":3477378,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-27T12:27:35.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 25, 2019 with respect to 18,500 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":18500,"derivative":{"exercise_price":4.64,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001694187-19-000052","document":"wf-form4_156163844021811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000169418719000052/wf-form4_156163844021811.xml","form_type":"4"}},{"id":3483336,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-20T22:00:22.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":1155,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6319,"source":{"system":"sec-edgar","filing":"0001127602-19-022431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219022431/form4.xml","form_type":"4"}},{"id":3514004,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2019-05-23T21:35:32.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 22, 2019."}],"balance_after":10000,"derivative":{"exercise_price":79.79,"exercise_date":"2019-06-22","expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-032388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919119032388/doc4.xml","form_type":"4"}},{"id":3526378,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-15T23:04:21.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of May 14, 2019, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":3.29,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-19-011355","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000156761919011355/doc1.xml","form_type":"4"}},{"id":3774851,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-05T21:15:34.000Z","date":"2018-10-31","kind":"gift","acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5164,"source":{"system":"sec-edgar","filing":"0001127602-18-032080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218032080/form4.xml","form_type":"4"}},{"id":3774850,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-05T21:15:34.000Z","date":"2018-10-31","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5339,"source":{"system":"sec-edgar","filing":"0001127602-18-032080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218032080/form4.xml","form_type":"4"}},{"id":3774849,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-05T21:15:34.000Z","date":"2018-10-31","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5539,"source":{"system":"sec-edgar","filing":"0001127602-18-032080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218032080/form4.xml","form_type":"4"}},{"id":3774848,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-05T21:15:34.000Z","date":"2018-10-31","kind":"gift","acquired":false,"shares":275,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5739,"source":{"system":"sec-edgar","filing":"0001127602-18-032080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218032080/form4.xml","form_type":"4"}},{"id":3894734,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T21:21:52.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6014,"source":{"system":"sec-edgar","filing":"0001127602-18-020935","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218020935/form4.xml","form_type":"4"}},{"id":3895975,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T16:34:32.000Z","date":"2018-06-11","kind":"sale","acquired":false,"shares":10000,"price":98.442,"value":984420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $97.46 to $99.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":47548,"source":{"system":"sec-edgar","filing":"0001209191-18-037379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118037379/doc4.xml","form_type":"4"}},{"id":3900470,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T21:24:52.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of June 6, 2018, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":6.6,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-18-027910","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000114036118027910/doc1.xml","form_type":"4"}},{"id":3917723,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2018-05-26T00:05:55.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 24, 2018."}],"balance_after":12500,"derivative":{"exercise_price":94.64,"exercise_date":"2018-06-24","expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-033640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118033640/doc4.xml","form_type":"4"}},{"id":3954081,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2018-04-30T20:03:34.000Z","date":"2018-04-26","kind":"exercise","acquired":false,"shares":15000,"price":7.05,"value":105750.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.05,"exercise_date":"2011-06-25","expiration_date":"2018-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-026832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118026832/doc4.xml","form_type":"4"}},{"id":3954080,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T20:03:34.000Z","date":"2018-04-26","kind":"tax_withholding","acquired":false,"shares":1331,"price":79.44,"value":105734.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2011, which, if unexercised would have expired on May 25, 2018. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's 2003 Incentive Stock Plan, as amended. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($7.05) was subtracted from the April 26, 2018 market close price ($79.44), and this net amount ($72.39) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,669 shares to the optionee. The 1,331 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program."}],"balance_after":57548,"source":{"system":"sec-edgar","filing":"0001209191-18-026832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118026832/doc4.xml","form_type":"4"}},{"id":3954079,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-30T20:03:34.000Z","date":"2018-04-26","kind":"exercise","acquired":true,"shares":15000,"price":7.05,"value":105750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2011, which, if unexercised would have expired on May 25, 2018. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's 2003 Incentive Stock Plan, as amended. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($7.05) was subtracted from the April 26, 2018 market close price ($79.44), and this net amount ($72.39) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,669 shares to the optionee. The 1,331 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program."}],"balance_after":58879,"source":{"system":"sec-edgar","filing":"0001209191-18-026832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118026832/doc4.xml","form_type":"4"}},{"id":4143214,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-05T21:29:20.000Z","date":"2017-11-29","kind":"gift","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5134,"source":{"system":"sec-edgar","filing":"0001127602-17-033932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033932/form4.xml","form_type":"4"}},{"id":4143213,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-05T21:29:20.000Z","date":"2017-11-29","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5534,"source":{"system":"sec-edgar","filing":"0001127602-17-033932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033932/form4.xml","form_type":"4"}},{"id":4143212,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-05T21:29:20.000Z","date":"2017-11-29","kind":"gift","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5734,"source":{"system":"sec-edgar","filing":"0001127602-17-033932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217033932/form4.xml","form_type":"4"}},{"id":4286150,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:19:35.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of June 8, 2017, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":13000,"derivative":{"exercise_price":10.55,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-17-039224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1079462/000120919117039224/doc4.xml","form_type":"4"}},{"id":4287716,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-06-09T21:54:16.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":1055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On 6/8/16 an RSU was awarded for 1,060 shares.  This award was adjusted to 1,084 shares pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":5984,"source":{"system":"sec-edgar","filing":"0001127602-17-021101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217021101/form4.xml","form_type":"4"}},{"id":4288879,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-08T22:37:01.000Z","date":"2017-05-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 22, 2017."}],"balance_after":15000,"derivative":{"exercise_price":53.64,"exercise_date":"2017-06-22","expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-038638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117038638/doc4.xml","form_type":"4"}},{"id":4462329,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2017-02-09T00:38:32.000Z","date":"2017-02-07","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.4,"exercise_date":"2010-05-25","expiration_date":"2017-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-008908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008908/doc4.xml","form_type":"4"}},{"id":4462328,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-09T00:38:32.000Z","date":"2017-02-07","kind":"tax_withholding","acquired":false,"shares":1169,"price":43.6,"value":50968.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2010, which, if unexercised would have expired on May 25, 2017. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's Equity Incentive Plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($3.40) was subtracted from the February 7, 2017 market close price ($43.60), and this net amount ($40.20) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,831 shares to the optionee. The 1,169 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program."}],"balance_after":43879,"source":{"system":"sec-edgar","filing":"0001209191-17-008908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008908/doc4.xml","form_type":"4"}},{"id":4462327,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-09T00:38:32.000Z","date":"2017-02-07","kind":"exercise","acquired":true,"shares":15000,"price":3.4,"value":51000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2010, which, if unexercised would have expired on May 25, 2017. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's Equity Incentive Plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($3.40) was subtracted from the February 7, 2017 market close price ($43.60), and this net amount ($40.20) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,831 shares to the optionee. The 1,169 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program."}],"balance_after":45048,"source":{"system":"sec-edgar","filing":"0001209191-17-008908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008908/doc4.xml","form_type":"4"}},{"id":4559126,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":2656,"kind":"person","name":"SHERWIN STEPHEN A","position":1,"cik":"0001079462","reported_name":"SHERWIN STEPHEN A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-14T21:32:23.000Z","date":"2016-11-08","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4905,"source":{"system":"sec-edgar","filing":"0001127602-16-066963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760216066963/form4.xml","form_type":"4"}}]}